Wells Fargo & Company Akouos, Inc. Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.16 $80 - $159	-31 Reduced 1.61%	1,900 $13,000
Q2 2022 Aug 12, 2022	SELL	$2.46 - $5.2 $3,901 - $8,247	-1,586 Reduced 45.1%	1,931 $9,000
Q1 2022 May 16, 2022	SELL	$4.16 - $9.08 $35,206 - $76,844	-8,463 Reduced 70.64%	3,517 $16,000
Q4 2021 Feb 14, 2022	BUY	$7.65 - $11.38 $87,171 - $129,675	11,395 Added 1947.86%	11,980 $102,000
Q2 2021 Aug 16, 2021	SELL	$11.87 - $15.96 $48,560 - $65,292	-4,091 Reduced 87.49%	585 $8,000
Q1 2021 May 13, 2021	SELL	$13.87 - $21.04 $208,119 - $315,705	-15,005 Reduced 76.24%	4,676 $65,000
Q4 2020 Feb 09, 2021	BUY	$17.03 - $22.45 $145,572 - $191,902	8,548 Added 76.78%	19,681 $390,000
Q3 2020 Nov 05, 2020	BUY	$19.3 - $26.92 $211,006 - $294,316	10,933 Added 5466.5%	11,133 $255,000
Q2 2020 Aug 13, 2020	BUY	$22.0 - $22.5 $4,400 - $4,500	200 New	200 $5,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.